Cyclacel Pharmaceuticals ( CYCC ) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now

2 weeks ago

Cyclacel Pharmaceuticals (CYCC) witnesses a hammer chart pattern, indicating support found by the stock after losing some value lately. This coupled with an upward trend in earnings estimate revisions could mean a trend reversal for the stock in the near term.

Ticker	Sentiment	Impact
CYCC	Bullish	42 %